Medicine and Dentistry
Radiation Therapy
100%
Prostate Cancer
76%
Oncology
45%
Overall Survival
18%
Clinical Trial
18%
External Beam Radiotherapy
17%
Intensity Modulated Radiation Therapy
16%
Prostate Specific Antigen
16%
Neoplasm
14%
Quality of Life
14%
Radiation Oncology
14%
Brachytherapy
13%
Conformal Radiotherapy
13%
Malignant Neoplasm
12%
Prostatectomy
11%
Androgen Deprivation Therapy
11%
Disease
10%
Bladder
10%
Pelvis
9%
Hazard Ratio
9%
Biochemical Recurrence
9%
Treatment Planning
9%
Arm
7%
Bladder Cancer
7%
Recurrent Disease
7%
Rhabdomyosarcoma
6%
Computer Assisted Tomography
6%
Carcinoma
6%
Stereotactic Body Radiation Therapy
6%
Patient-Reported Outcome
6%
Drug Megadose
6%
Gleason Score
6%
Distant Metastasis
6%
Proton Therapy
5%
Nuclear Magnetic Resonance
5%
Urinary System
5%
Dose-Volume Histogram
5%
Disease Free Survival
5%
Randomized Clinical Trial
5%
Keyphrases
Radiation Therapy
44%
Prostate Cancer
34%
Radiation Therapy Oncology Group
23%
Radiotherapy
19%
Overall Survival
18%
External Beam Radiotherapy
16%
Prostate-specific Antigen
16%
Prostate
15%
Radiation Oncology
15%
Androgen Deprivation Therapy
14%
NRG Oncology
12%
Three-dimensional Conformal Radiotherapy
11%
Intensity-modulated Radiation Therapy
11%
Localized Prostate Cancer
10%
Quality of Life
10%
Prostate Carcinoma
9%
Clinical Trials
9%
Hazard Ratio
9%
Confidence Interval
8%
Radiation Therapy for Prostate Cancer
8%
Oncology
8%
Brachytherapy
8%
Salvage Radiotherapy
7%
Distant Metastasis
7%
Quality Assurance
7%
Tumor
7%
Biochemical Failure
7%
American Society
7%
Intermediate-risk Prostate Cancer
7%
Multi-institutional
7%
Rhabdomyosarcoma
7%
Radical Prostatectomy
7%
Prostate Cancer Patients
7%
Bladder Cancer
6%
High-grade Prostate Cancer
6%
Prostate-specific Antigen Level
6%
Prostate Radiotherapy
6%
Bowel
6%
Treatment Planning
6%
Patient-reported Outcomes
6%
Phase II Trial
6%
Chemotherapy
5%
High Dose
5%
Radiation Dose
5%
Dose Escalation
5%
Dose Level
5%
Children's Oncology Group
5%
Randomized Clinical Trial
5%